Sino Biopharmaceutical Li...

OTC: SBMFF · Real-Time Price · USD
0.99
0.00 (0.10%)
At close: Aug 13, 2025, 12:40 PM
0.99
0.00%
After-hours: Aug 13, 2025, 08:00 PM EDT

Sino Biopharmaceutical Income Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
28.87B 26.2B 28.78B 26.86B
Cost of Revenue
5.34B 4.99B 5.8B 5.33B
Gross Profit
23.53B 21.21B 22.98B 21.53B
Operating Income
6.28B 5.79B 6.69B 18.86B
Interest Income
n/a 186.68M 201.44M 162.06M
Pretax Income
5.28B 5.41B 5.78B 18.57B
Net Income
3.5B 2.33B 5B 14.61B
Selling & General & Admin
12.16B 11.07B 12.56B 12.7B
Research & Development
5.09B 4.47B 4.33B 3.75B
Other Expenses
n/a n/a n/a 4.48B
Operating Expenses
17.11B 15.42B 16.95B 17.19B
Interest Expense
n/a 495.24M 439.06M 308.62M
Selling & Marketing Expenses
10.08B 9.19B 10.36B 10.52B
Cost & Expenses
22.45B 20.53B 22.74B 22.52B
Income Tax Expense
492.92M 797.27M 775.99M 1.96B
Shares Outstanding (Basic)
17.24B 23.39B 18.62B 18.77B
Shares Outstanding (Diluted)
18.3B 18.53B 19.02B 19.28B
EPS (Basic)
0.20 0.08 0.27 0.78
EPS (Diluted)
0.19 0.10 0.26 0.73
EBITDA
6.11B 6.98B 6.69B 19.87B
EBIT
5.17B 5.91B 5.64B 18.88B
Depreciation & Amortization
939.85M 1.07B 1.05B 992.56M